Check-Cap Ltd

7CC

Company Profile

  • Business description

    Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

  • Contact

    29 Abba Hushi Avenue
    Check-Cap Building, P.O. Box 1271
    Isfiya3009000
    ISR

    T: +972 48303400

    E: [email protected]

    https://www.check-cap.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    85

Stocks News & Analysis

stocks

Are investors missing the boat on this future ASX leader?

The market is underestimating the clear path to profitability.
stocks

ASX shares plunge but remain undervalued

Shares drop 17% after guidance is revised but we still see value.
stocks

Ask the analyst: Why have markets shunned APA Group?

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,456.8015.00-0.18%
CAC 407,423.6715.030.20%
DAX 4020,271.33138.480.69%
Dow JONES (US)42,518.28221.160.52%
FTSE 1008,201.5422.65-0.28%
HKSE19,238.3918.610.10%
NASDAQ19,044.3943.71-0.23%
Nikkei 22538,384.6189.69-0.23%
NZX 50 Index12,943.5759.190.46%
S&P 5005,842.916.690.11%
S&P/ASX 2008,213.3017.70-0.22%
SSE Composite Index3,228.6112.33-0.38%

Market Movers